glp-1 blood clots meds might reduce clot risk in diabetes patients GLP-1 Drugs Cut Death, Blood
Description
2011 doi: 10.1152/ajpregu.00424.2010
2025, [6] E
They help reduce bloating, constipation, and other digestive issues, while enhancing nutrient absorption
Following GLP-1 RA therapy, patients' reduced inflammation and improved insulin sensitivity may enhance responsiveness to these generic medications
The first of these trials, the STEP 1 trial, compared 2.4 mg of weekly semaglutide plus lifestyle intervention with placebo plus lifestyle intervention for 68 weeks in obese nondiabetic patients, and the result showed a clinically significant and sustained average weight loss among the semaglutide group (14.9%) and a difference of 12.4% compared to the placebo and lifestyle group (2.4% mean weight loss) [29]
Glucagon-like peptide-1 receptor agonists and muscle mass effects
